Product Overview
Compounded Injectable Semaglutide is a GLP-1 receptor agonist formulated for subcutaneous injection. It is used to support appetite regulation and blood glucose control under medical supervision.
How It Works
Semaglutide activates the GLP-1 receptor, which helps regulate appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion. These actions may reduce food intake and support metabolic regulation.
Safety Information
This medication may not be appropriate for all individuals.
Do not use if you have:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Use caution and consult a healthcare provider if you have:
- A history of pancreatitis
- Gallbladder disease
- Kidney disease or dehydration
- Severe gastrointestinal disorders
- Diabetic retinopathy
- A history of thyroid disease
GLP-1 receptor agonists have been associated with thyroid C-cell tumors in animal studies. The relevance of this finding to humans is unknown.
Risk of hypoglycemia may increase when used with insulin or insulin secretagogues.
Delayed gastric emptying may affect the absorption of oral medications.
Common Side Effects
Commonly reported side effects may include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal pain
Decreased appetite
Fatigue
Headache
Dizziness
More serious adverse reactions may include pancreatitis, gallbladder disease, kidney injury, or severe gastrointestinal symptoms. Seek medical attention if symptoms are severe or persistent.
Compounding Disclosure
This medication is compounded by a licensed pharmacy and is not FDA-approved. Compounded medications are prepared based on a healthcare provider’s prescription to meet individual patient needs.